Literature DB >> 17632683

Parvovirus B19 infection associated with dilated cardiomyopathy in patients with previous anthracycline exposure.

C J McMahon1, H Murchan, T Prendiville, M Burch.   

Abstract

We describe two children with previous anthracycline exposure for cancer who presented with acute decompensated left ventricular dysfunction. Both patients had evidence of dilated cardiomyopathy and required mechanical ventilation and inotropic support. Parvovirus B19 was detected by polymerase chain reaction of the blood. After several weeks of ventilation and inotropic support, both patients were weaned from ventilation and managed with oral carvedilol, ACE inhibition, and diuretics. Acute left ventricular decompensation in patients following anthracycline exposure may not be solely attributed to drug exposure, and viral etiologies should be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632683     DOI: 10.1007/s00246-006-0147-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Myocarditis associated with parvovirus B19 infection in two siblings with merosin-deficient congenital muscular dystrophy.

Authors:  M Beghetti; A Gervaix; C A Haenggeli; M Berner; P C Rimensberger
Journal:  Eur J Pediatr       Date:  2000 Jan-Feb       Impact factor: 3.183

2.  Genomic organization and chromosomal localization of the human Coxsackievirus B-adenovirus receptor gene.

Authors:  K R Bowles; J Gibson; J Wu; L G Shaffer; J A Towbin; N E Bowles
Journal:  Hum Genet       Date:  1999-10       Impact factor: 4.132

Review 3.  Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.

Authors:  G Nigro; V Bastianon; V Colloridi; F Ventriglia; P Gallo; G D'Amati; W C Koch; S P Adler
Journal:  Clin Infect Dis       Date:  2000-07-14       Impact factor: 9.079

4.  Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction.

Authors:  K O Schowengerdt; J Ni; S W Denfield; R J Gajarski; N E Bowles; G Rosenthal; D L Kearney; J K Price; B B Rogers; G M Schauer; R E Chinnock; J A Towbin
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

5.  Early identification of anthracycline cardiomyopathy: possibilities and implications.

Authors:  F A Bu'Lock; M G Mott; A Oakhill; R P Martin
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

6.  The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.

Authors:  Steven E Lipshultz; Nader Rifai; Virginia M Dalton; Donna E Levy; Lewis B Silverman; Stuart R Lipsitz; Steven D Colan; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall A Schorin; Richard D Gelber; Stephen E Sallan
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

7.  Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.

Authors:  T Nousiainen; E Vanninen; E Jantunen; J Remes; J Kuikka; J Hartikainen
Journal:  Clin Physiol       Date:  2001-01

8.  Cardiotropic viruses in the myocardium of children with end-stage heart disease.

Authors:  Paola Francalanci; Jamie L Chance; Matteo Vatta; Shinawe Jimenez; Hua Li; Jeffrey A Towbin; Neil E Bowles
Journal:  J Heart Lung Transplant       Date:  2004-09       Impact factor: 10.247

9.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

Authors:  Neil E Bowles; Jiyuan Ni; Debra L Kearney; Matthias Pauschinger; Heinz-Peter Schultheiss; Robert McCarthy; Joshua Hare; J Timothy Bricker; Karla R Bowles; Jeffrey A Towbin
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

10.  Three cases of myocarditis in childhood associated with human parvovirus (B19 virus).

Authors:  K Munro; M C Croxson; S Thomas; N J Wilson
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.838

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.